跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,896 条关于
“BK channels”
全部
4,896
临床试验
4,166
药物
118
机构
13
资讯
599
去年
Servier Acquires KER-0193 for $450M to Target Fragile X Syndrome, Marking First Neurology Asset
2年前
FDA Grants Orphan Drug Status to Spinogenix's SPG601 for Fragile X Syndrome
2年前
Spinogenix Receives FDA Orphan Drug Designation for SPG601 to Treat Fragile X Syndrome
去年
Enalare Therapeutics Receives FDA Clearance for Phase 1 Study of ENA-001 in the US
去年
Kaerus Bioscience's KER-0193 Receives FDA Orphan and Rare Pediatric Drug Designations for Fragile X Syndrome
去年
Spinogenix's SPG601 Shows Promise in Phase 2 Trial for Fragile X Syndrome
2年前
Kaida BioPharma Advances Novel Therapies for Gynecological Cancers, Launches Social Media Channels
去年
Study Calls for Optimization of High-Cost IVIG Therapy in BK Nephropathy Treatment
去年
Memo Therapeutics Demonstrates Therapeutic Antibodies Can Cross Kidney Barrier, Supporting BK Virus Treatment Approach
去年
SpikImm Secures Worldwide License for Anti-BK Virus Monoclonal Antibodies to Protect Transplant Patients
第 1 页,共 60 页
上一页
下一页